Skip to main content
ACS AuthorChoice logoLink to ACS AuthorChoice
. 2022 Jul 25;17(8):2377–2378. doi: 10.1021/acschembio.2c00545

Correction to “Mitochondrial Protease ClpP Is a Target for the Anticancer Compounds ONC201 and Related Analogues”

Paul R Graves, Lucas J Aponte-Collazo, Emily M J Fennell, Adam C Graves, Andrew E Hale, Nedyalka Dicheva, Laura E Herring, Thomas S K Gilbert, Michael P East, Ian M McDonald, Matthew R Lockett, Hani Ashamalla, Nathaniel J Moorman, Donald S Karanewsky, Edwin J Iwanowicz, Ekhson Holmuhamedov, Lee M Graves
PMCID: PMC9484722  PMID: 35878877

Upon inspection it was discovered that Figure 1E contained a duplicate Western blot image for the protein CHOP. Specifically, the ONC201 blot (left panel) was identical to the TR57 blot (right panel). The original ONC201 blot has now been inserted into the correct panel. We do not believe that the new blot image changes the conclusions of these studies.

Figure 1.

Figure 1

ONC201 and TR analogues inhibit cell growth and induce ATF4 and CHOP activation. (a) Chemical structures of ONC201 and TR compounds. (b) Cell viability of ONC201 and TR compounds using MTS assay in SUM159 cells. IC50 values are shown in the table at left (a). Data shown as mean ± SEM, representative of N = 4 replicates. (c) Growth of SUM159 cells determined by crystal violet assay, representative of N = 3 replicates. (d) Changes in cell number determined by Hoechst stain, representative of N = 2 replicates. (e) Immunoblots of SUM159 lysates for ATF4, CHOP, and β-actin.


Articles from ACS Chemical Biology are provided here courtesy of American Chemical Society

RESOURCES